Establishing a Robust Quality System in a 503B Outsourcing Facility American Pharmaceutical Review A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read FDA puts some peptides off limits Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # BPC 157 & TB 500 Blend 10mg 10mg Peptide Tech What's NEXT for BPC 157 and Independent Pharmacies from @olympiapharmaceuticals ?